Intrinsic Value of S&P & Nasdaq Contact Us

High Fusion Inc. SPLIF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

High Fusion Inc. (SPLIF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 43/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — SPLIF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-1.51 $0.00 $-681.16K -
2015 $-0.45 $202.27K $-2.06M -1018.1%
2016 $-0.35 $535.32K $-2.31M -431.3%
2017 $-0.45 $660.22K $-5.01M -758.2%
2018 $-0.72 $5.81M $-9.71M -166.9%
2019 $-1.78 $23.61M $-27.7M -117.3%
2020 $-1.34 $11.05K $-22.09M -199860.8%
2021 $-0.04 $96.07K $-1.85M -1925.3%
2022 $-0.22 $6.25M $-18.97M -303.6%
2023 $0.00 $0.00 $0.00 -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message